FLUCOXEL

This brand name is authorized in Nigeria.

Active ingredients

The drug FLUCOXEL contains one active pharmaceutical ingredient (API):

1
UNII 8VZV102JFY - FLUCONAZOLE
 

Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.

 
Read more about Fluconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100422 Powder Flucoxel Dusting Powder PWD 2% 100G 137 NF-CS-231108 Flucoxel Dusting Powder Fluconazole B.P 2% Fluconazole B.P 2% DRUGS Imported Products 100g Prescription Only Medicine (POM) 10/11/2021 EXCEL CHARIS PHARMACEUTICAL CHEMICAL LIMITED, OGUNGBESAN STREET, COKER ORILE LAGOS LAGOS Accretion Pharmaceuticals, 29, Xcelon Industrial Park-I, Behind INTAS Pharmaceuticals, Vasana-Chacharwadi, Ta-Sanand, Dist. Ahmedabad-382213, Gujarat India., India 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D01AC15 Fluconazole D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100422

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.